Karuna Therapeutics Financials

Karuna Therapeutics Stock Summary

Karuna Therapeutics competes with Blueprint Medicines, Amylyx Pharmaceuticals, Day One, X4 Pharmaceuticals, and Inozyme Pharma. Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Karuna Therapeutics, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts. Karuna Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 118 people.

Karuna Therapeutics Key Financial Ratios

Karuna Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Karuna Therapeutics's current stock value. Our valuation model uses many indicators to compare Karuna Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Karuna Therapeutics competition to find correlations between indicators driving Karuna Therapeutics's intrinsic value. More Info.Karuna Therapeutics is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Karuna Therapeutics' earnings, one of the primary drivers of an investment's value.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

If you are still planning to invest in Karuna Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Karuna Therapeutics' history and understand the potential risks before investing.